Header Logo

Jessica Chubak

Concepts (295)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
18
2022
445
5.520
Why?
Colorectal Neoplasms
39
2024
615
4.580
Why?
Early Detection of Cancer
32
2025
513
4.040
Why?
Colonoscopy
20
2024
253
2.530
Why?
Survivors
6
2018
150
2.460
Why?
Breast Neoplasms
22
2020
957
2.250
Why?
Neoplasm Recurrence, Local
11
2018
247
2.130
Why?
Mass Screening
20
2024
678
1.940
Why?
Humans
96
2025
17822
1.910
Why?
Aged
66
2025
6173
1.870
Why?
Middle Aged
63
2025
8020
1.580
Why?
Electronic Health Records
7
2023
698
1.530
Why?
Occult Blood
13
2024
154
1.530
Why?
Algorithms
5
2020
239
1.470
Why?
Female
73
2025
12780
1.460
Why?
Cancer Survivors
3
2022
85
1.410
Why?
Health Services Research
4
2016
232
1.320
Why?
Adaptation, Psychological
4
2018
77
1.280
Why?
Guideline Adherence
4
2025
158
1.140
Why?
Male
45
2024
10145
1.080
Why?
Animal Assisted Therapy
2
2017
5
1.070
Why?
Child, Hospitalized
2
2017
14
1.060
Why?
Aged, 80 and over
22
2024
1931
1.060
Why?
Washington
17
2020
383
1.020
Why?
Antidepressive Agents
3
2015
156
1.000
Why?
Adenoma
7
2024
94
0.960
Why?
Uterine Cervical Neoplasms
5
2025
125
0.910
Why?
Practice Guidelines as Topic
7
2025
321
0.880
Why?
Risk Factors
19
2023
3362
0.880
Why?
United States
19
2024
4007
0.860
Why?
Comparative Effectiveness Research
3
2013
66
0.830
Why?
Postmenopause
7
2009
243
0.820
Why?
Epidemiologic Methods
2
2012
81
0.790
Why?
Adult
25
2025
7708
0.780
Why?
Bias
4
2022
103
0.750
Why?
Diabetes Mellitus
2
2018
487
0.730
Why?
Colonic Neoplasms
2
2019
158
0.720
Why?
Neoplasms, Second Primary
4
2018
29
0.710
Why?
Quality of Life
4
2018
511
0.690
Why?
Delivery of Health Care, Integrated
8
2017
537
0.690
Why?
Return to Work
1
2019
2
0.670
Why?
Oropharyngeal Neoplasms
1
2019
6
0.660
Why?
Patient Acceptance of Health Care
4
2022
391
0.650
Why?
Follow-Up Studies
10
2020
1219
0.650
Why?
Surveys and Questionnaires
8
2019
1323
0.640
Why?
Adenocarcinoma
4
2022
173
0.630
Why?
Proportional Hazards Models
6
2019
711
0.630
Why?
Carcinoma, Squamous Cell
1
2019
55
0.630
Why?
Age Factors
5
2024
923
0.590
Why?
Papillomavirus Infections
3
2025
139
0.570
Why?
Liver Cirrhosis
1
2017
35
0.570
Why?
Sensitivity and Specificity
6
2022
305
0.570
Why?
Carcinoma, Hepatocellular
1
2017
26
0.560
Why?
Health Expenditures
1
2018
76
0.550
Why?
Time Factors
6
2019
1097
0.550
Why?
Liver Neoplasms
1
2017
40
0.550
Why?
Cohort Studies
14
2025
2590
0.530
Why?
Anticarcinogenic Agents
1
2016
13
0.520
Why?
Feces
2
2016
80
0.520
Why?
Reproducibility of Results
2
2015
381
0.520
Why?
Patient Satisfaction
1
2017
212
0.520
Why?
Oncology Service, Hospital
1
2015
1
0.510
Why?
Employment
1
2016
43
0.510
Why?
Bonding, Human-Pet
1
2015
2
0.510
Why?
Endometrial Neoplasms
2
2007
35
0.510
Why?
Colonic Polyps
3
2023
35
0.510
Why?
Research
2
2013
65
0.510
Why?
Paroxetine
1
2015
23
0.510
Why?
Aspirin
1
2016
63
0.500
Why?
Mammography
3
2015
169
0.500
Why?
Population Surveillance
1
2017
264
0.500
Why?
Primary Prevention
1
2016
73
0.500
Why?
Insurance Coverage
1
2016
106
0.490
Why?
Uterine Cervical Dysplasia
3
2025
8
0.480
Why?
Psychometrics
1
2015
121
0.480
Why?
Antidepressive Agents, Tricyclic
2
2013
9
0.470
Why?
Insurance, Health
1
2016
183
0.470
Why?
Retrospective Studies
13
2023
2467
0.470
Why?
Practice Patterns, Physicians'
1
2017
332
0.460
Why?
Carcinoma, Ductal, Breast
2
2012
53
0.460
Why?
Professional Role
1
2013
10
0.450
Why?
Delivery of Health Care
6
2022
417
0.430
Why?
Epidemiologic Studies
1
2013
29
0.430
Why?
Medical Oncology
1
2013
32
0.430
Why?
Depressive Disorder
1
2015
222
0.430
Why?
Cardiovascular Diseases
2
2016
599
0.430
Why?
Preventive Medicine
1
2013
24
0.420
Why?
Behavioral Sciences
1
2012
2
0.420
Why?
Clinical Trials as Topic
1
2013
132
0.410
Why?
Health Personnel
1
2013
126
0.400
Why?
Reminder Systems
5
2017
80
0.400
Why?
Health Status Indicators
1
2012
64
0.390
Why?
Heart Diseases
1
2012
77
0.390
Why?
Health Policy
1
2012
123
0.380
Why?
Logistic Models
6
2018
928
0.360
Why?
Serotonin Uptake Inhibitors
1
2011
71
0.350
Why?
Registries
6
2019
472
0.350
Why?
Databases, Factual
1
2011
315
0.340
Why?
Animals
3
2017
262
0.340
Why?
Postal Service
5
2019
73
0.340
Why?
Drug Prescriptions
1
2011
151
0.330
Why?
Exercise
4
2007
495
0.330
Why?
Histamine H2 Antagonists
1
2009
13
0.320
Why?
Disease Progression
3
2016
267
0.320
Why?
Proton Pump Inhibitors
1
2009
24
0.320
Why?
Young Adult
10
2025
2464
0.320
Why?
Case-Control Studies
8
2023
1120
0.320
Why?
Patient Compliance
4
2017
301
0.310
Why?
Breast
1
2009
85
0.300
Why?
Health Care Costs
1
2010
229
0.300
Why?
Estrogens
2
2007
61
0.290
Why?
Research Design
5
2013
376
0.290
Why?
Predictive Value of Tests
3
2013
354
0.290
Why?
Progestins
1
2007
25
0.290
Why?
Estrogen Replacement Therapy
1
2007
99
0.280
Why?
Colposcopy
2
2023
4
0.270
Why?
Dogs
2
2017
17
0.270
Why?
Lung Neoplasms
3
2022
260
0.270
Why?
Thinness
1
2006
30
0.260
Why?
Odds Ratio
6
2019
673
0.260
Why?
Bone Density
1
2006
97
0.260
Why?
Hospitals, Pediatric
2
2017
79
0.250
Why?
Neoplasm Staging
7
2017
330
0.250
Why?
Cost-Benefit Analysis
2
2024
250
0.250
Why?
Antineoplastic Agents, Hormonal
2
2018
64
0.250
Why?
Adolescent
6
2019
3690
0.240
Why?
Patient Navigation
2
2015
15
0.240
Why?
Anxiety
2
2018
151
0.240
Why?
SEER Program
5
2020
91
0.240
Why?
Follicle Stimulating Hormone
1
2004
3
0.230
Why?
Estradiol
1
2004
24
0.230
Why?
Risk Assessment
5
2019
1103
0.230
Why?
Sex Hormone-Binding Globulin
1
2004
23
0.230
Why?
Patient-Centered Care
2
2016
197
0.220
Why?
Vaginal Smears
4
2025
48
0.210
Why?
Biomarkers, Tumor
1
2004
144
0.210
Why?
Survival Rate
2
2013
260
0.200
Why?
Primary Health Care
3
2022
770
0.200
Why?
Cross-Sectional Studies
4
2024
1335
0.200
Why?
Reproductive History
2
2017
17
0.200
Why?
Tamoxifen
2
2018
56
0.180
Why?
Intestinal Polyps
1
2020
7
0.170
Why?
Patient Selection
2
2012
190
0.170
Why?
Prostatic Neoplasms
1
2022
262
0.170
Why?
Interviews as Topic
2
2013
305
0.170
Why?
Symptom Assessment
1
2019
6
0.170
Why?
Child
2
2017
2497
0.170
Why?
Linear Models
3
2011
232
0.160
Why?
Papillomaviridae
3
2025
58
0.160
Why?
Socioeconomic Factors
3
2019
630
0.160
Why?
Cytochrome P-450 CYP2D6
1
2018
1
0.160
Why?
Educational Status
1
2019
200
0.160
Why?
Motivation
1
2019
131
0.150
Why?
Evidence-Based Medicine
1
2019
186
0.150
Why?
Diabetes Complications
1
2018
114
0.150
Why?
Pediatric Nursing
1
2017
3
0.140
Why?
Healthcare Disparities
2
2019
204
0.140
Why?
Ultrasonography
1
2017
36
0.140
Why?
Incidence
2
2016
1269
0.140
Why?
Nurses
2
2015
36
0.140
Why?
Contraceptives, Oral
1
2017
26
0.140
Why?
Comorbidity
2
2016
597
0.140
Why?
National Cancer Institute (U.S.)
1
2016
16
0.140
Why?
Analgesics, Opioid
1
2019
246
0.130
Why?
Pilot Projects
1
2017
219
0.130
Why?
Overweight
3
2007
270
0.130
Why?
Specimen Handling
1
2016
20
0.130
Why?
Antihypertensive Agents
1
2017
161
0.130
Why?
Risk
2
2015
518
0.130
Why?
Medical Records
1
2015
100
0.120
Why?
Health Surveys
1
2016
261
0.120
Why?
Inpatients
1
2015
81
0.120
Why?
Hypoglycemic Agents
1
2017
272
0.120
Why?
Outpatients
1
2015
110
0.120
Why?
Prognosis
3
2015
609
0.120
Why?
Self Efficacy
1
2014
68
0.110
Why?
Cardiovascular Agents
1
2014
24
0.110
Why?
Patient Advocacy
1
2013
13
0.110
Why?
Reagent Kits, Diagnostic
1
2013
10
0.110
Why?
Depressive Disorder, Major
1
2015
124
0.110
Why?
Observer Variation
1
2013
37
0.110
Why?
Utilization Review
1
2013
53
0.110
Why?
Selection Bias
1
2013
19
0.110
Why?
Observation
1
2013
23
0.110
Why?
Patient Care Planning
1
2013
53
0.110
Why?
Health Promotion
1
2016
281
0.110
Why?
Confidence Intervals
3
2013
237
0.110
Why?
Societies, Medical
1
2013
75
0.110
Why?
Confounding Factors (Epidemiology)
1
2013
86
0.110
Why?
Lymphoma, Non-Hodgkin
1
2013
24
0.110
Why?
Counseling
1
2015
189
0.110
Why?
Continuity of Patient Care
2
2011
105
0.110
Why?
Patient Preference
1
2013
48
0.110
Why?
Effect Modifier, Epidemiologic
1
2012
9
0.100
Why?
Recurrence
1
2013
189
0.100
Why?
Survival Analysis
1
2013
216
0.100
Why?
Hypertension
1
2017
505
0.100
Why?
Translational Medical Research
1
2012
35
0.100
Why?
Ovariectomy
1
2012
9
0.100
Why?
Outcome and Process Assessment (Health Care)
1
2012
102
0.100
Why?
Genetic Counseling
1
2012
26
0.100
Why?
Clinical Coding
1
2011
11
0.100
Why?
Program Evaluation
1
2012
223
0.100
Why?
Drug Administration Schedule
2
2012
100
0.100
Why?
Ovarian Neoplasms
1
2012
50
0.090
Why?
Anti-Bacterial Agents
1
2013
142
0.090
Why?
Specialization
1
2011
24
0.090
Why?
Randomized Controlled Trials as Topic
1
2012
329
0.090
Why?
Treatment Outcome
4
2015
1265
0.090
Why?
False Positive Reactions
1
2010
26
0.090
Why?
Longitudinal Studies
3
2020
720
0.090
Why?
Depression
1
2015
506
0.090
Why?
Diabetes Mellitus, Type 2
1
2017
755
0.090
Why?
Anti-Ulcer Agents
1
2009
5
0.080
Why?
Medication Adherence
1
2012
246
0.080
Why?
Ambulatory Care
1
2011
247
0.080
Why?
Phenotype
2
2020
151
0.080
Why?
Antineoplastic Agents
1
2009
59
0.080
Why?
Telephone
3
2017
161
0.080
Why?
Health Behavior
2
2012
360
0.080
Why?
Prospective Studies
1
2012
1286
0.080
Why?
Carcinoma, Lobular
1
2007
10
0.070
Why?
Referral and Consultation
1
2009
169
0.070
Why?
Sigmoidoscopy
3
2013
65
0.070
Why?
Pregnancy
2
2023
1529
0.070
Why?
Prolactin
1
2007
4
0.070
Why?
Medicare
2
2017
205
0.070
Why?
Multivariate Analysis
1
2007
569
0.060
Why?
Outcome Assessment (Health Care)
2
2017
228
0.060
Why?
Texas
1
2025
35
0.060
Why?
Quality-Adjusted Life Years
1
2024
38
0.060
Why?
Menstrual Cycle
1
2004
5
0.060
Why?
Androgens
1
2004
13
0.060
Why?
Testosterone
1
2004
23
0.060
Why?
Probability
1
2004
79
0.060
Why?
Parity
1
2004
74
0.060
Why?
Adipose Tissue
1
2004
64
0.060
Why?
Aromatase
1
2004
8
0.060
Why?
Steroid 17-alpha-Hydroxylase
1
2004
5
0.060
Why?
Aryl Hydrocarbon Hydroxylases
1
2004
6
0.060
Why?
Age Distribution
1
2004
246
0.060
Why?
Gonadal Steroid Hormones
1
2004
27
0.060
Why?
Polymorphism, Genetic
1
2004
63
0.060
Why?
Office Visits
2
2016
80
0.050
Why?
Obesity
2
2007
842
0.050
Why?
Papanicolaou Test
1
2022
37
0.050
Why?
Prostate-Specific Antigen
1
2022
75
0.050
Why?
California
2
2019
2328
0.050
Why?
Self Report
2
2013
253
0.050
Why?
Body Mass Index
4
2007
967
0.050
Why?
Proto-Oncogene Proteins B-raf
1
2020
15
0.040
Why?
Data Warehousing
1
2020
3
0.040
Why?
Pandemics
1
2022
287
0.040
Why?
DNA Methylation
1
2020
41
0.040
Why?
Weight Loss
1
2022
305
0.040
Why?
Medical History Taking
1
2019
35
0.040
Why?
Mutation
1
2020
131
0.040
Why?
Financial Support
1
2019
5
0.040
Why?
Biopsy
1
2019
75
0.040
Why?
Demography
1
2019
101
0.040
Why?
Age of Onset
1
2019
79
0.040
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2018
2
0.040
Why?
Disease-Free Survival
1
2018
58
0.040
Why?
Attitude to Health
1
2019
165
0.040
Why?
Sulfonylurea Compounds
1
2017
25
0.040
Why?
Metformin
1
2017
58
0.030
Why?
Insulin
1
2017
213
0.030
Why?
Aftercare
1
2016
49
0.030
Why?
Sex Factors
1
2015
644
0.030
Why?
Idaho
1
2013
24
0.030
Why?
Costs and Cost Analysis
1
2013
80
0.030
Why?
Aromatase Inhibitors
1
2012
33
0.020
Why?
Treatment Refusal
1
2012
33
0.020
Why?
Residence Characteristics
1
2014
251
0.020
Why?
Regression Analysis
1
2012
300
0.020
Why?
Analysis of Variance
1
2011
159
0.020
Why?
Nursing Care
1
2010
4
0.020
Why?
Nursing Staff, Hospital
1
2010
11
0.020
Why?
Sample Size
1
2010
29
0.020
Why?
Quality Control
1
2010
45
0.020
Why?
Allied Health Personnel
1
2010
12
0.020
Why?
Genetic Predisposition to Disease
1
2012
376
0.020
Why?
Continental Population Groups
1
2012
302
0.020
Why?
Data Collection
1
2010
257
0.020
Why?
Chronic Disease
1
2011
428
0.020
Why?
Long-Term Care
1
2007
22
0.020
Why?
Feeding Behavior
1
2007
166
0.020
Why?
Radioimmunoassay
1
2004
4
0.010
Why?
Catechol O-Methyltransferase
1
2004
1
0.010
Why?
Cytochrome P-450 CYP1B1
1
2004
2
0.010
Why?
Health Knowledge, Attitudes, Practice
1
2007
382
0.010
Why?
Alleles
1
2004
85
0.010
Why?
Genotype
1
2004
227
0.010
Why?
Body Weight
1
2004
224
0.010
Why?
Tomography, X-Ray Computed
1
2004
211
0.010
Why?
Concepts (295)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente